Menu Close

Our science

SAM0021

Our second autophagy-inducing candidate, SAM0021 is a promising treatment for Parkinson’s Disease. Supported by funding from the Michael J. Fox Foundation, we’ve accelerated our research with the aim of moving into clinical trials by the end of 2024*.

*deck indicates filing for IND in 2024; Samsara to confirm timing for clinical trial